U.S. FDA approves Amgen migraine drug, price set at $6900/yr
May 17, 2018 at 19:07 PM EDT
May 17 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Amgen Inc's drug Aimovig for the prevention of migraine headaches in adults.